Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
VNRX
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct | 1,640 Added 3.95% |
-
|
Apr 07
2022 |
|
VNRX
|
Martin Charles Faulkes
Executive Director |
BUY
Grant, award, or other acquisition
|
Direct | 8,443 Added 0.55% |
-
|
Apr 07
2022 |
|
VNRX
|
Cameron John Reynolds
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 17,375 Added 1.48% |
-
|
Apr 07
2022 |
|
VNRX
|
Terig Hughes
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,759 Added 50.0% |
-
|
Apr 07
2022 |
|
DRMA
|
David F Hale |
BUY
Grant, award, or other acquisition
|
Direct | 15,466 Added 44.71% |
-
|
Apr 07
2022 |
|
DRMA
|
Brittany Bradrick |
BUY
Grant, award, or other acquisition
|
Direct | 5,031 Added 50.0% |
-
|
Apr 07
2022 |
|
DRMA
|
Andrew Seth Sandler |
BUY
Grant, award, or other acquisition
|
Direct | 5,190 Added 50.0% |
-
|
Apr 07
2022 |
|
DRMA
|
Kathleen D. Scott |
BUY
Grant, award, or other acquisition
|
Direct | 5,826 Added 50.0% |
-
|
Apr 07
2022 |
|
DRMA
|
Mary Fisher |
BUY
Grant, award, or other acquisition
|
Direct | 5,031 Added 50.0% |
-
|
Apr 07
2022 |
|
DRMA
|
Wendell Wierenga |
BUY
Grant, award, or other acquisition
|
Direct | 10,593 Added 40.64% |
-
|
Apr 07
2022 |
|
CRTD
|
Jeremy Frommer
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 1,203 Added 0.21% |
$1,251
$1.04 p/Share
|
Apr 07
2022 |
|
AMPG
|
Daniel Richard Mazziota
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 3.52% |
$14,000
$2.8 p/Share
|
Apr 07
2022 |
|
AEI
|
Heng Fai Ambrose Chan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 4,377,792 Added 10.52% |
$3,108,232
$0.71 p/Share
|
Apr 07
2022 |
|
ZVO
|
George P. Pernsteiner
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,450 Added 18.16% |
-
|
Apr 07
2022 |
|
CGRN
|
Frederick S. Hencken Iii
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 29,655 Added 26.34% |
-
|
Apr 07
2022 |
|
CGRN
|
Darren Jamison
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 47,654 Added 18.29% |
-
|
Apr 07
2022 |
|
WMC
|
Greg E. Handler
Interim Co-CIO |
BUY
Open market or private purchase
|
Direct | 14,468 Added 13.92% |
$22,570
$1.56 p/Share
|
Apr 07
2022 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,633
$4.23 p/Share
|
Apr 07
2022 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$11,633
$4.23 p/Share
|
Apr 07
2022 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$11,633
$4.23 p/Share
|
Apr 07
2022 |
|
TBNK
|
Vernon Hirata
Vice Chairman & Co-COO |
SELL
Open market or private sale
|
Direct | 3,546 Reduced 4.09% |
$83,083
$23.43 p/Share
|
Apr 07
2022 |
|
TRC
|
Steven A. Betts |
BUY
Grant, award, or other acquisition
|
Direct | 866 Added 2.55% |
$15,813
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Michael H Winer |
BUY
Grant, award, or other acquisition
|
Direct | 866 Added 4.46% |
$15,813
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Geoffrey L Stack |
BUY
Grant, award, or other acquisition
|
Indirect | 1,277 Added 1.51% |
$23,318
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Rhea Frawn Morgan |
BUY
Grant, award, or other acquisition
|
Direct | 661 Added 16.21% |
$12,070
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Norman J Metcalfe |
BUY
Grant, award, or other acquisition
|
Indirect | 1,003 Added 1.38% |
$18,315
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Anthony L. Leggio |
BUY
Grant, award, or other acquisition
|
Direct | 866 Added 2.1% |
$15,813
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Susan K Hori
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,071 Added 42.99% |
$19,556
$18.26 p/Share
|
Apr 07
2022 |
|
TRC
|
Jeannie Lynn Fuller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 661 Added 6.74% |
$12,070
$18.26 p/Share
|
Apr 07
2022 |
|
IRMD
|
Roger E. Susi
CEO, PRESIDENT, CHAIRMAN |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 1.49% |
$453,500
$45.35 p/Share
|
Apr 07
2022 |
|
GCI
|
Douglas Edward Horne
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 8,345 Reduced 1.33% |
$35,216
$4.22 p/Share
|
Apr 07
2022 |
|
BWB
|
Mary Jayne Crocker
EVP & CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 14,750 Added 7.8% |
$44,250
$3.0 p/Share
|
Apr 07
2022 |
|
GEVO
|
Paul D Bloom
Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,061 Reduced 0.94% |
$18,599
$4.58 p/Share
|
Apr 07
2022 |
|
RIOT
|
Hubert Marleau |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 100.0% |
$44,325
$17.73 p/Share
|
Apr 07
2022 |
|
HMST
|
Sandra A Cavanaugh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 265 Added 2.24% |
-
|
Apr 07
2022 |
|
HMST
|
James R Mitchell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 227 Added 2.87% |
-
|
Apr 07
2022 |
|
HMST
|
Mark Robert Patterson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 277 Added 1.71% |
-
|
Apr 07
2022 |
|
HMST
|
Nancy D Pellegrino
Director |
BUY
Grant, award, or other acquisition
|
Direct | 505 Added 8.1% |
-
|
Apr 07
2022 |
|
HMST
|
Douglas Irvine Smith
Director |
BUY
Grant, award, or other acquisition
|
Direct | 601 Added 0.58% |
-
|
Apr 07
2022 |
|
HMST
|
Joanne R Harrell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 161 Added 50.0% |
-
|
Apr 07
2022 |
|
PLYA
|
Karl Peterson Mr. |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.97% |
$240,900
$8.03 p/Share
|
Apr 07
2022 |
|
AVID
|
Garrard Brown
Chief Accounting Officer & VP |
SELL
Payment of exercise price or tax liability
|
Direct | 923 Reduced 2.05% |
$31,853
$34.51 p/Share
|
Apr 07
2022 |
|
ADPT
|
R Mark Adams
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 831 Reduced 0.67% |
$10,944
$13.17 p/Share
|
Apr 07
2022 |
|
CTKB
|
Wenbin Jiang
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.25% |
$210,800
$10.54 p/Share
|
Apr 07
2022 |
|
WOW
|
David Brunick
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 0.91% |
$40,000
$20.0 p/Share
|
Apr 07
2022 |
|
WOW
|
Teresa L Elder
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 1.04% |
$300,000
$20.0 p/Share
|
Apr 07
2022 |
|
WOW
|
Donald Craig Martin
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.63% |
$400,000
$20.0 p/Share
|
Apr 07
2022 |
|
PLAY
|
Margo Lynn Manning
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,061 Reduced 0.76% |
-
|
Apr 07
2022 |
|
PLAY
|
John Mulleady
Former Chief Dev Ofc |
SELL
Payment of exercise price or tax liability
|
Direct | 660 Reduced 0.99% |
-
|
Apr 07
2022 |
|
PAY
|
Gerasimos (Jerry) Portocalis
Chief Commercial Officer |
BUY
Conversion of derivative security
|
Direct | 323,250 Added 46.57% |
-
|
Apr 07
2022 |